Elite in Pulmonary Embolism
Check Dr. Rachel P. Rosovsky's experience treating your condition:
About Dr. Rachel P. Rosovsky

Rachel Rosovsky is a Hematologist Oncology expert in Newton, Massachusetts. Rosovsky has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in the treatment of Pulmonary Embolism. She is also highly rated in 23 other conditions, according to our data. Her top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, and Shwartzman Phenomenon. She is licensed to treat patients in Massachusetts. Rosovsky is currently accepting new patients.

Her clinical research consists of co-authoring 89 peer reviewed articles and participating in 5 clinical trials in the past 15 years. In particular, she has co-authored 36 articles and participated in 2 clinical trials in the study of Pulmonary Embolism.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rachel P. Rosovsky it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
2014 Washington St, Newton, MA 02462
Other Locations
55 Fruit St, Boston, MA 02114
Background & Education
Graduate Institution
Harvard Medical School, 2000
Hematology Oncology
Internal Medicine in MA
Hospital Affiliations
Winchester Hospital
Brigham And Womens Hospital
Massachusetts General Hospital
Newton-Wellesley Hospital
North Shore Medical Center - Salem Hospital
Marthas Vineyard Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
A Phase II Study to Evaluate the Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
View 3 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors